Ola Weiland
Professor
Medicine
Karolinska Institutet
Sweden
Biography
Dr. Ola Weiland is currently working as Professor in the Department of Medicine, Huddinge (MedH), H7, Karolinska Institutet, Sweden. Ola Weiland research interest includes Infectious Diseases and has successfully completed their Administrative responsibilities. Ola Weiland has authored of many research articles related to Infectious Diseases.
Research Interest
Infectious Diseases
Publications
-
Feld JJ, Kowdley KV, Coakley E, Sigal S, Nelson DR, Crawford D, Weiland O, Aguilar H, Xiong J, Pilot-Matias T, DaSilva-Tillmann B. Treatment of HCV with ABT-450/r–ombitasvir and dasabuvir with ribavirin. New England Journal of Medicine. 2014 Apr 24;370(17):1594-603.
-
Reichard O, Norkrans G, Frydén A, Braconier JH, Sönnerborg A, Weiland O, Swedish Study Group. Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C. The Lancet. 1998 Jan 10;351(9096):83-7.
-
Zeuzem S, Andreone P, Pol S, Lawitz E, Diago M, Roberts S, Focaccia R, Younossi Z, Foster GR, Horban A, Ferenci P. Telaprevir for retreatment of HCV infection. New England Journal of Medicine. 2011 Jun 23;364(25):2417-28.
